PMV PHARMACEUTICALS, INC. Reclassifications of Temporary to Permanent Equity
PMV PHARMACEUTICALS, INC. (PMVP) reported Reclassifications of Temporary to Permanent Equity of -$238.72 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Shareholders' Equity
us-gaap:ReclassificationsOfTemporaryToPermanentEquity · last filed 2023-03-01
- PMV PHARMACEUTICALS, INC. reclassifications of temporary to permanent equity for the quarter ending 2020-09-30 was -$238.72M.
- PMV PHARMACEUTICALS, INC. reclassifications of temporary to permanent equity for fiscal 2020 was -$238.72M.
| Period end | Reclassifications of Temporary to Permanent Equity 3 month | Reclassifications of Temporary to Permanent Equity 12 month |
|---|---|---|
| 2020-12-31 | -$238.72M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$238.72M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |